【行业研究报告】医药生物-医药行业：板块短期承压，静待后续改善

济川药业3932-32%1022-46%859-49%1183-33%298-47%239-54%
济川药业3932-32%1022-46%859-49%1183-33%298-47%239-54%
天士力6311-2%98417%829-16%2022-3%21017%189-24%
步长制药8469-1%868178%855138%2805-9%241195%23671%
众生药业1889-1%25168%24630%5898%632%59301%
奇正藏药15233%4248%2824%348-25%65-4%-8-
江中药业2933-6%6836%6404%792-8%1615%1589%
羚锐制药304110%65113%60512%94210%17710%16310%
马应龙28372%50110%4684%8883%1588%1464%
康恩贝49761%58413%4312%161710%23069%13553%
太极集团8088-22%166-70%91-82%2430-7%27-46%-29-194%